logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10912800 B1

PDFFull Text
Date of Patent:
Feb. 09, 2021

Filed:

Nov. 22, 2016

Compositions and methods for treating type 1 and type 2 diabetes and related disorders

Applicant:

Salk Institute for Biological Studies, La Jolla, CA (US);

Inventors:

Ronald M. Evans, La Jolla, CA (US);

Eiji Yoshihara, La Jolla, CA (US);

Michael R. Downes, La Jolla, CA (US);

Ruth T. Yu, La Jolla, CA (US);

Annette R. Atkins, La Jolla, CA (US);

Assignee:

SALK INSTITUTE FOR BIOLOGICAL STUDIES, La Jolla, CA (US);

Attorneys:

Melissa Hunter-Ensor

Leslie Serunian

Greenberg Traurig, LLP

Primary Examiner:

Thaian N Ton

Assistant Examiner:

David A Montanari

Int. Cl.
CPC ...
A61K 35/39 (2015.01); C12N 5/071 (2010.01); C07K 14/705 (2006.01); C07K 14/72 (2006.01); A61K 48/00 (2006.01); A61K 35/12 (2015.01); A61K 35/35 (2015.01); A61K 35/51 (2015.01); A61K 35/545 (2015.01); C12N 15/85 (2006.01); C12N 15/86 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/39 (2013.01); A61K 35/12 (2013.01); A61K 35/35 (2013.01); A61K 35/51 (2013.01); A61K 35/545 (2013.01); A61K 48/00 (2013.01); C07K 14/70567 (2013.01); C07K 14/721 (2013.01); C12N 5/0676 (2013.01); C12N 15/85 (2013.01); C12N 15/86 (2013.01); A61K 38/00 (2013.01); C12N 2501/105 (2013.01); C12N 2501/115 (2013.01); C12N 2501/392 (2013.01); C12N 2501/415 (2013.01); C12N 2506/02 (2013.01); C12N 2510/00 (2013.01); C12N 2710/10032 (2013.01); C12N 2710/10043 (2013.01);
Abstract

The invention features compositions comprising in vitro generated beta cells capable of glucose-stimulated insulin secretion, methods of inducing beta cell maturation from embryonic or induced pluripotent stem cell-derived beta-like cells, and methods of using in vitro generated beta cells for the treatment of type 1 diabetes, type 2 diabetes, or a related disorder.

Find Patent Forward Citations

Evans, Ronald. (2021). Compositions and methods for treating type 1 and type 2 diabetes and related disorders (U.S. Patent No. 10912800). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10912800

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…